HARVARD BIOSCIENCE, INC. Cash and Cash Equivalents, Period Increase (Decrease)
HARVARD BIOSCIENCE, INC. (HBIO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.24 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-08
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$96.00K.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$3.14M, a 1318.22% decline year-over-year.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $1.51M.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $1.04M, a 6.74% decline year-over-year.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $2.44M, a 1681.02% increase from fiscal 2017.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $137.00K.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.15M.
- HARVARD BIOSCIENCE, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$7.39M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2019-06-30 | -$96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$3.24M 10-Q · filed 2019-08-08 | -$1.73M derived: sum of 3 quarters · filed 2019-08-08 | -$690.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2019-03-31 | -$3.14M 10-Q · filed 2019-05-08 | -$1.63M derived: sum of 2 quarters · filed 2019-05-08 | -$594.00K derived: sum of 3 quarters · filed 2019-05-08 | -$961.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.55M derived: sum of 2 quarters · filed 2019-03-18 | $2.18M derived: sum of 3 quarters · filed 2019-08-08 | $2.44M 10-K · filed 2019-03-18 | |
| 2018-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $670.00K derived: sum of 2 quarters · filed 2019-08-08 | $928.00K 10-Q · filed 2018-11-01 | $825.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-06-30 | -$367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$109.00K 10-Q · filed 2019-08-08 | -$212.00K derived: sum of 3 quarters · filed 2019-08-08 | $900.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $258.00K 10-Q · filed 2019-05-08 | $155.00K derived: sum of 2 quarters · filed 2019-05-08 | $1.27M derived: sum of 3 quarters · filed 2019-05-08 | $1.39M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.01M derived: sum of 2 quarters · filed 2019-03-18 | $1.13M derived: sum of 3 quarters · filed 2019-03-18 | $137.00K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.24M derived: sum of 2 quarters · filed 2018-11-01 | $240.00K 10-Q · filed 2018-11-01 | $491.00K derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$872.00K 10-Q · filed 2018-08-02 | -$621.00K derived: sum of 3 quarters · filed 2018-08-02 | $1.09M derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | -$997.00K 10-Q · filed 2018-05-10 | -$746.00K derived: sum of 2 quarters · filed 2018-05-10 | $968.00K derived: sum of 3 quarters · filed 2018-05-10 | $424.00K derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.97M derived: sum of 2 quarters · filed 2018-03-16 | $1.42M derived: sum of 3 quarters · filed 2018-03-16 | -$1.15M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.17M derived: sum of 2 quarters · filed 2017-11-02 | -$1.40M 10-Q · filed 2017-11-02 | -$745.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$3.11M 10-Q · filed 2017-08-03 | -$2.46M derived: sum of 3 quarters · filed 2018-03-16 | -$3.77M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | -$2.57M 10-Q · filed 2017-05-08 | -$1.92M derived: sum of 2 quarters · filed 2018-03-16 | -$3.23M derived: sum of 3 quarters · filed 2018-03-16 | -$3.86M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$658.00K derived: sum of 2 quarters · filed 2018-03-16 | -$1.29M derived: sum of 3 quarters · filed 2018-03-16 | -$7.39M 10-K · filed 2018-03-16 | |
| 2015-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.94M derived: sum of 2 quarters · filed 2016-11-03 | -$8.04M 10-Q · filed 2016-11-03 | -$20.64M derived: sum of 4 quarters · filed 2017-03-17 | |
| 2015-06-30 | -$629.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$6.73M 10-Q · filed 2016-08-04 | -$19.33M derived: sum of 3 quarters · filed 2017-03-17 | -$19.03M derived: sum of 4 quarters · filed 2017-03-17 | |
| 2015-03-31 | -$6.10M 10-Q · filed 2016-05-16 | -$18.70M derived: sum of 2 quarters · filed 2017-03-17 | -$18.40M derived: sum of 3 quarters · filed 2017-03-17 | -$17.81M derived: sum of 4 quarters · filed 2017-03-17 | |
| 2014-12-31 | -$12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$12.30M derived: sum of 2 quarters · filed 2017-03-17 | -$11.70M derived: sum of 3 quarters · filed 2017-03-17 | -$11.64M 10-K · filed 2017-03-17 | |
| 2014-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $897.00K derived: sum of 2 quarters · filed 2015-11-05 | $963.00K 10-Q · filed 2015-11-05 | -$10.20M derived: sum of 4 quarters · filed 2016-04-29 | |
| 2014-06-30 | $597.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $663.00K 10-Q · filed 2015-08-06 | -$10.50M derived: sum of 3 quarters · filed 2016-04-29 | -$7.66M derived: sum of 4 quarters · filed 2016-04-29 | |
| 2014-03-31 | $66.00K 10-Q · filed 2015-05-07 | -$11.09M derived: sum of 2 quarters · filed 2016-04-29 | -$8.26M derived: sum of 3 quarters · filed 2016-04-29 | $2.09M derived: sum of 4 quarters · filed 2016-04-29 | |
| 2013-12-31 | -$11.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$8.33M derived: sum of 2 quarters · filed 2016-04-29 | $2.02M derived: sum of 3 quarters · filed 2016-04-29 | $5.09M 10-K · filed 2016-04-29 | |
| 2013-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $13.18M derived: sum of 2 quarters · filed 2014-11-06 | $16.25M 10-Q · filed 2014-11-06 | $16.65M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $10.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $13.42M 10-Q · filed 2014-08-07 | $13.81M derived: sum of 3 quarters · filed 2015-03-12 | $15.44M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $3.07M 10-Q · filed 2014-05-08 | $3.46M derived: sum of 2 quarters · filed 2015-03-12 | $5.09M derived: sum of 3 quarters · filed 2015-03-12 | $5.88M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $2.03M derived: sum of 2 quarters · filed 2015-03-12 | $2.82M derived: sum of 3 quarters · filed 2015-03-12 | $2.77M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $2.42M derived: sum of 2 quarters · filed 2013-11-08 | $2.37M 10-Q · filed 2013-11-08 | $4.05M derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-06-30 | $791.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $739.00K 10-Q · filed 2013-08-09 | $2.42M derived: sum of 3 quarters · filed 2014-03-14 | -$3.09M derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-03-31 | -$52.00K 10-Q · filed 2013-05-10 | -$679.00K 10-Q · filed 2012-05-10 | $1.63M derived: sum of 2 quarters · filed 2014-03-14 | -$3.88M derived: sum of 3 quarters · filed 2014-03-14 | -$2.22M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$3.83M derived: sum of 2 quarters · filed 2014-03-14 | -$2.17M derived: sum of 3 quarters · filed 2014-03-14 | -$1.79M 10-K · filed 2014-03-14 | |
| 2011-09-30 | -$5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$3.85M derived: sum of 2 quarters · filed 2012-11-08 | -$3.47M 10-Q · filed 2012-11-08 | -$980.00K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $2.04M 10-Q · filed 2012-08-09 | $4.53M derived: sum of 3 quarters · filed 2013-03-18 | $6.03M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $384.00K 10-Q · filed 2012-05-10 | $2.87M derived: sum of 2 quarters · filed 2013-03-18 | $4.37M derived: sum of 3 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $3.98M derived: sum of 2 quarters · filed 2013-03-18 | $3.12M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $629.00K 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | -$869.00K 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | $2.89M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |